Drug Discovery

How a scattershot lunar alliance launched a cybernetic rocket at SARS-CoV-2

Where did DNDi come from – and where is it going? We ask the nonprofit organization’s chief for a rundown

Ukrainian drug discovery has been disrupted by war. We spoke to leaders of its largest player about the domestic industry’s past, present, and future.

What will drug development look like aboard a new commercial space station?

This 6 episode miniseries will take listeners behind the scenes of a range of projects at the Drugs for Neglected Diseases initiative

How bioelectronic assays helped demonstrate the value of 3D iPSC cultures in modeling human brain development.

Are all antibiotics doomed to eventual impotence? New work from Oxford could change the game by defeating resistance itself.

Thorben Seeger wants to democratize the data held by the world’s leading genomic institutions. But what exactly does he mean by “democratize”?

Our eBook features drug development stories, a drive for novel excipients, new technologies, and more.

Boston bioscientists have found an unlikely ally in anthrax toxins, which could form the basis for a new kind of painkiller.